Showing results (671-680 of 713) with videos related to
Sort By:
Pageof 72
Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.Annals of Surgery|September 25, 2025
Implementation of Comprehensive Surgical Guidelines for Hepatoblastoma: Analysis of the Children's Oncology Group AHEP0731 Phase III TrialZachary J Kastenberg, Sanjeev A Vasudevan, Lucy Dolmadjian, et al.Journal of Neurosurgery|October 9, 2020
Intraoperative MRI for newly diagnosed supratentorial glioblastoma: a multicenter-registry comparative study to conventional surgeryAmar S Shah, Peter T Sylvester, Alexander T Yahanda, et al.Cancer Immunology Research|October 31, 2023
Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology SymposiumChristopher Alvarez-Breckenridge, Kristin G Anderson, Ana Luisa Correia, et al.NPJ Digital Medicine|September 1, 2022
A method for intelligent allocation of diagnostic testing by leveraging data from commercial wearable devices: a case study on COVID-19Md Mobashir Hasan Shandhi, Peter J Cho, Ali R Roghanizad, et al.Neurosurgery|August 18, 2020
Using Histopathology to Assess the Reliability of Intraoperative Magnetic Resonance Imaging in Guiding Additional Brain Tumor Resection: A Multicenter StudyAmar S Shah, Alexander T Yahanda, Peter T Sylvester, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent GlioblastomaLakshmi Nayak, Nathan Standifer, Jorg Dietrich, et al.American Journal of Ophthalmology|October 12, 2018
Factors Associated With Graft Rejection in the Cornea Preservation Time StudyR Doyle Stulting, Jonathan H Lass, Mark A Terry, et al.Bioorganic & Medicinal Chemistry Letters|July 18, 2008
Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptaseZachary K Sweeney, James P Dunn, Yu Li, et al.Cancer|November 11, 2021
Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group studyHoward M Katzenstein, Marcio H Malogolowkin, Mark D Krailo, et al.Pageof 72